Ignite Creation Date:
2025-12-24 @ 2:43 PM
Ignite Modification Date:
2026-01-17 @ 10:05 PM
Study NCT ID:
NCT03634059
Status:
UNKNOWN
Last Update Posted:
2018-08-16
First Post:
2018-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Apatinib Plus EGFR-TKI as First Line Treatment in Patients With Non-squamous NSCLC Harboring EGFR Mutations
Sponsor:
Hebei Medical University Fourth Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2019-08-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-08-15
Completion Date Type:
ESTIMATED
First Submit Date:
2018-07-12
First Submit QC Date:
None
Study First Post Date:
2018-08-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-14
Last Update Post Date:
2018-08-16
Last Update Post Date Type:
ACTUAL